P. Lagarde
Argonne National Laboratory
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. Lagarde.
Cancer Radiotherapie | 2017
E. Blais; B. Pichon; A. Mampuya; M. Antoine; P. Lagarde; G. Kantor; C. Breton-Callu; C. Lefebvre; M. Gerard; A. Aamarcha; M. Ozsahin; J. Bourhis; P. Maingon; I. Troussier; N. Pourel
Radiation-induced lung disease (RILD) is common after radiation therapy and represents cornerstone toxicities after treatment of thoracic malignancies. From a review of literature, the objective of this article was to summarize clinical and non-clinical parameters associated with the risk of RILD in the settings of normo-fractionated radiotherapy and stereotactic body radiation therapy (SBRT). For the treatment of lung cancers with a normo-fractionated treatment, the mean lung dose (MLD) should be below 15-20Gy. For a thoracic SBRT, V20Gy<10% and MLD<6Gy are recommended. One should pay attention to central tumors and respect specific dose constraints to the bronchial tree. The recent technological improvements may represent an encouraging way to decrease lung toxicities. Finally, our team developed a calculator in order to predict the risk of radiation pneumonitis.
Cancer Radiotherapie | 2005
M. Lapeyre; P. Henrot; M. Alfonsi; E. Bardet; R.J. Bensadoun; G. Dolivet; V. Favrel; O. Gallocher; P. Giraud; P. Graff; S. Guerif; P. Lagarde; E. Lartigau; V. Marchesi; P. Pommier; Michel Rives; J. Tortochaux; B. Toussaint; P. Verrelle; Jean-Henri Bourhis; G. Calais; Groupe oncologie radiothérapie tête et cou
Cancer Radiotherapie | 2005
M. Lapeyre; P. Henrot; M. Alfonsi; E. Bardet; René-Jean Bensadoun; G. Dolivet; V. Favrel; O. Gallocher; P. Giraud; P. Graff; S. Guerif; P. Lagarde; E. Lartigau; V. Marchesi; Pascal Pommier; Michel Rives; J. Tortochaux; B. Toussaint; Gilles Calais
Cancer Radiotherapie | 2004
E. Musat; G. Kantor; J. Caron; P. Lagarde; H. Laharie; E. Stoeckle; J. Angles; L. Gilbeau; Binh Bui
Cancer Radiotherapie | 2005
Y. Milbéo; G. Kantor; H. Laharie; P. Lagarde; E. Stoeckle; F. Bonichon; L. Thomas; Véronique Brouste; Binh Bui
Cancer Radiotherapie | 2000
N Tawfiq; P. Lagarde; Eberhard Stöckle; L. Thomas; Binh Bui; G. Kantor
Cancer Radiotherapie | 2008
L. Donnay; C. Dejean; E. Amsellem; H. Bourezgui; B.H. de Figueiredo; A. Duparc; J. Caron; H. Tournat; P. Lagarde; E. Stoeckle; G. Kantor
Cancer Radiotherapie | 2006
Y. Milbéo; G. Kantor; P. Lagarde; E. Stoeckle; A. Duparc; L. Thomas; Binh Bui
Cancer Radiotherapie | 2016
Dupin C; Vilotte F; P. Lagarde; A. Petit; C. Breton-Callu
Cancer Radiotherapie | 2015
Dupin C; F. Villote; P. Lagarde; A. Petit; C. Breton-Callu
